Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation

Leukemia and Lymphoma

Volumn 44, Issue 5, 2003, Pages 815-820

  Gordan, L N ^a   Sugrue, M W ^b   Lynch, J W ^a   Williams, K D ^b   Khan, S A ^a   Wingard, J R ^a   Moreb, J S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Autologous transplantation; Lymphoma; Poor mobilization; Prognosis; Stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; THIOTEPA;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BODY WEIGHT; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STATISTICAL ANALYSIS; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; CELL COUNT; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0037403201     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000067585     Document Type: Article

References (24)

1. Mink, S.A., Armitage, J.O. (2001) "High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma", The Oncologist 6, 247-256.
2. Armitage, J.O. (2000) "High-dose chemotherapy and autologous hematopoietic stem cell transplantation: the lymphoma experience and its potential relevance to solid tumors", Oncology 58, 198-206.
3. Vose, J.M. (1998) "High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma", Annals of Oncology 9(Suppl. 1), S1-S3.
4. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", New England Journal of Medicine 333, 1540-1545.
5. Cagnoni, P.J. and Shpall, E.J. (1996) "Mobilization and selection of CD34-positive hematopoietic progenitors", Blood Review 10, 1-7.
6. Stadtmauer, E.A., Schneider, C.J. and Silberstein, L.E. (1995) "Peripheral blood progenitor cell generation and harvesting", Seminars in Oncology 22, 291-300.
7. To, L.B., Haylock, D.N., Simmons, P.J. and Juttner, C.A. (1997) "The biology and clinical uses of blood stem cells", Blood 89, 2233-2258.
8. Leitman, S.F. and Read, E.J. (1996) "Hematopoietic progenitor cell", Seminars in Hematology 33, 341-358.
9. Demirer, T., Buckner, C.D., Gooley, T., Appkelbaum, F.B., Rowley, S., Chauncey, T., Lilieby, K., Storb, R., Bensinger, W.I. (1996) "Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma", Bone Marrow Transplantion 17, 937-941.
10. Lie, A.K., Rawling, T.P., Bayly, J.L. and To, L.B. (1996) "Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy", British Journal of Haematology 95, 39-44.
11. Narayanasami, U., Kanteti, R., Morelli, J., Klekar, A., Al-Olama, A., Keating, C., O'Connor, C., Berkman, E., Erban, J.K., Sprague, K.A., Miller, K.B. and Schenkein, D.P. (2001) "Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation", Blood 98, 2059-2064.
12. Sugrue, M.W., Williams, K., Pollock, B.H., Khan, S., Peracha, S., Wingard, J.R. and Moreb, J.S. (2000) "Characterization and outcome of hard to mobilize lymphoma patients undergoing autologous stem cell transplantation", Leukemia and Lymphoma 39, 509-519.
13. Kaplan, E. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", Journal of American Statistics Association 135, 186-206.
14. Cox, D.R. (1972) "Regression models and life tables", Journal of Research Statistical Society 34, 187-220.
15. Ketterer, N., Salles, G., Moullet, I., Dumontet, C., ElJaafari-Corbin, A., Tremisi, P., Thieblemont, C., Durand, B., Neidhardt-Berard, E.M., Samaha, H., Rigal, D. and Coiffier, B. (1998) "Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies", British Journal of Haematology 103, 235-242.
16. Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. and Hunstein, W. (1994) "Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma", Blood 3, 3787-3794.
17. Passos-Coelho, J.L., Braine, H.G., Davis, J.M., Huelskamp, A.M., Schepers, K.G., Ohly, K., Clarke, B., Wright, S.K., Noga, S.J., Davidson, N.E. (1995) "Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization", Journal of Clinical Oncology 13, 705-714.
18. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C. (1995) "Factors that influence collection and engraftment of autologous peripheral-blood stem cells", Journal of Clinical Oncology 13, 2547-2555.
19. Dreger, P., Kloss, M., Peterson, B., Haferlach, T., Loffler, H., Loeffler, M. and Schmitz, N. (1997) "Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts", Blood 86, 3970-3978.
20. Weaver, C.H., Potz, J., Redmond, J., Tauer, K., Schwartzberg, L.S., Kaywin, P., Drapkin, R., Grant, B., Unger, P., Allen, C., Longin, K., Zhen, B., Hazelton, B. and Buckner, C.D. (1997) "Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content", Bone Marrow Transplantion 19, 1103-1110.
21. Gordan, L.N., Sugrue, M.W., Williams, K.D., Khan S.A., Wingard J.R., Moreb J.S. (2001) "Correlation of absolute lymphocyte count recovery and CD34+ cell dose after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's lymphoma", Blood 98, 681a.
22. Porrata, L.F., Gertz, M.A., Inwards, D.J., Litzow, M.R., Lacy, M.Q., Tefferi, A., Gastineau, D.A., Dispenzieri, A., Ansell, S.M., Micallef, I.N., Geyer, S.M. and Markovic, S.N. (2001) "Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma", Blood 98, 579-585.
23. Stockerl-Goldstein, K.E., Reddy, S.A., Horning, S.F., Blume, K.G., Chao, N.F., Hu, W.W., Johnston, L.F., Long, G.D., Strober, S., Wong, R.M., Feiner, R.H., Kobler, S. and Negrin, R.S. (2000) "Favorable treatment outcome in non-Hodgkin's lymphoma patients with poor mobilization of peripheral blood progenitor cells", Biology of Blood and Marrow Transplantion 6, 506-512.
24. Schimmer, A.D., Jamal, S., Messner, H., Keating, A., Meharchand, J., Huebsch, L., Walker, I., Benger, A., Gluck, S. and Smith, A. (2000) "Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada", Bone Marrow Transplantion 26, 859-864.